Tandem Diabetes Care Inc (TNDM): Next-Year EPS Estimate 121.15%
As of 2026-09-03, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 121.15%. Featured in our EPS revision report on 2026-07-20.
On 2026-08-21, analyst consensus for TNDM's next-year EPS growth shifted from 121.61% to 121.15% — a negative change of 0.46 percentage points. The revised estimate has been sustained across 13 subsequent trading sessions. Current-year growth is projected at 54.02%.
What's Driving This
TNDM's rise is primarily supported by an upward revision to next-year EPS growth estimates, which were raised from 113.09% to 119.85% on July 16 and have since ticked up to 121.15%. The upgrade follows strong quarterly results and the company's announcement that it will file its tubeless insulin pump with the FDA this quarter, a potential catalyst for future growth. Continued momentum in the estimate revision suggests sentiment has stayed positive beyond the initial change.
Generated 2026-09-03 from news as of 2026-09-03
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 121.15%
- EPS growth this year
- 54.02%
- EPS next quarter (est)
- -$0.24
- Last price
- $20.13
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-03 | 121.15% | 54.02% | -$0.24 | $20.13 |
| 2026-09-02 | 121.15% | 54.02% | -$0.24 | $20.56 |
| 2026-09-01 | 121.15% | 54.02% | -$0.24 | $21.28 |
| 2026-08-31 | 121.15% | 54.02% | -$0.24 | $22.01 |
| 2026-08-30 | 121.15% | 54.02% | -$0.24 | $21.43 |
| 2026-08-29 | 121.15% | 54.02% | -$0.24 | $21.43 |
| 2026-08-28 | 121.15% | 54.02% | -$0.24 | $21.43 |
| 2026-08-27 | 121.15% | 54.02% | -$0.24 | $21.40 |
| 2026-08-26 | 121.15% | 54.02% | -$0.24 | $21.37 |
| 2026-08-25 | 121.15% | 54.02% | -$0.24 | $21.58 |
| 2026-08-24 | 121.15% | 54.02% | -$0.24 | $22.22 |
| 2026-08-23 | 121.15% | 54.02% | -$0.24 | $22.32 |
| 2026-08-21 | 121.15% | 54.02% | -$0.24 | $22.32 |
| 2026-08-20 | 121.61% | 54.07% | -$0.24 | $22.57 |
| 2026-08-19 | 121.61% | 54.07% | -$0.24 | $23.46 |
| 2026-08-18 | 121.61% | 54.07% | -$0.24 | $23.73 |
| 2026-08-17 | 121.61% | 54.07% | -$0.24 | $22.25 |
| 2026-08-16 | 123.61% | 54.17% | -$0.24 | $22.72 |
| 2026-08-14 | 123.61% | 54.17% | -$0.24 | $22.72 |
| 2026-08-13 | 123.61% | 54.17% | -$0.24 | $23.13 |
| 2026-08-12 | 123.61% | 54.17% | -$0.24 | $23.44 |
| 2026-08-11 | 123.59% | 54.16% | -$0.24 | $23.44 |
| 2026-08-10 | 123.59% | 54.16% | -$0.24 | $22.81 |
| 2026-08-09 | 122.11% | 53.41% | -$0.24 | $22.38 |
| 2026-08-07 | 122.11% | 53.41% | -$0.24 | $22.38 |
| 2026-08-06 | 118.87% | 53.89% | -$0.32 | $18.79 |
| 2026-08-05 | 118.87% | 53.89% | -$0.32 | $19.59 |
| 2026-08-04 | 118.87% | 53.89% | -$0.32 | $20.20 |
| 2026-08-03 | 118.87% | 53.89% | -$0.32 | $20.11 |
| 2026-08-02 | 118.87% | 53.89% | -$0.32 | $19.50 |
Reports Featuring TNDM
Recent News
Screen Performance
Aggregate stats across all 2025 tickers our top-EPS-revision screen has flagged over the past 155 days.
- Median return since detection
- +2.1%
- % of tickers in the green
- 54%
- Median return on winners
- +20.7%
- Large revisions captured
- 1657
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Tandem Diabetes Care Inc's next-year EPS growth estimate?▾
As of 2026-09-03, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 121.15%, based on analyst consensus.
When was the latest EPS estimate revision for TNDM?▾
The most recent revision occurred on 2026-08-21, when analysts adjusted the next-year EPS growth estimate from 121.61% to 121.15%.
What sector and industry does Tandem Diabetes Care Inc belong to?▾
Tandem Diabetes Care Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TNDM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Tandem Diabetes Care Inc (TNDM) appears here because it was detected by our daily top-EPS-revision-performer screen.